UK pharmacists are demanding a change in the culture around provision of Medicines Use Reviews, Chemist + Druggist reports. C+D polled its readers about MURs following controversy over allegations Boots was pressuring its pharmacists to peform the reviews where they were not necessary and aiming for the 400-a-year cap as a target. 45% of C+D
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.